Metabolic syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age between 18y-60y, ASA?-?, volunteer to participate in this study and sign the informed consent; 2. All met the diagnosis of metabolic syndrome and underwent surgery.
Exclusion criteria
Exclusion criteria: 1. There are serious cardiovascular system diseases and insufficiency of liver and kidney functions. 2. Patients with mental disorders or those who have difficulty communicating and cooperating. 3. Patients with cheek defects, trauma, or those who refuse acupuncture.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The dosage of sufentanil during the operation;The recovery quality of the patients at 24 hours and 48 hours after the operation;The level of plasma TNF-a in patients;The level of plasma ß -endorphin in patients;The level of plasma IL-6 in patients;The level of plasma CRP in patients;Visual Analogue Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative blood loss volume;Analgesia-related adverse reactions-vomiting;The dosage of propofol during the operation;;The length of hospital stay of patients;needle-related adverse reactions-bleeding;Analgesia-related adverse reactions-nausea;Intraoperative intravenous infusion volume;needle-related adverse reactions-fainting during acupuncture;Insomnia Severity Index;Intraoperative urine volume;Analgesia-related adverse reactions-pruritus;The time when the patient first passes gas after the surgery;The dosage of remifentanil during the operation;The number of manual compressions of the postoperative analgesic pump;Analgesia-related adverse reactions-respiratory depression;The patient satisfaction;Extubation time;The time when the patient first gets out of bed and moves around after surgery;The number of remedial analgesics;Needle-related adverse reactions-infection;The names and dosages of the drugs for remedial analgesia;Anesthesia time; | — |
Countries
China
Contacts
Huai'an First People's Hospital